Table 2 Annual trends in total deaths and proportionate mortality by sex, age group and disease condition
|  | Overall | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Kendall’s tau-B (p-value, Kendall’s score, SE) |
|---|---|---|---|---|---|---|---|---|---|---|---|
Total deaths (%) | 18,099 | 1737 (9.6) | 2558 (14.1) | 2597 (14.4) | 2418 (13.4) | 2290 (12.7) | 1866 (10.3) | 1763 (9.7) | 1609 (8.9) | 1261 (7.0) | − 0.61 (0.03, − 22, 9.59) |
Mortality rate (%) | 16.7 | 12.6 | 16.7 | 17.8 | 17.5 | 17.2 | 17.8 | 17.2 | 17.6 | 16.4 | 0.17 (0.60, 6, 9.59) |
Sex | |||||||||||
 Female (%) | 8425 (46.5) | 830(47.8) | 1189 (46.5) | 1191 (45.9) | 1107 (45.8) | 1066 (46.6) | 873 (46.8) | 807 (45.8) | 739 (45.9) | 623 (49.4) | 0.00 (> 0.99, 0, 9.59) |
Age mean (STD) | 46.2 (19.9) | 44.3 (19.0) | 43.8 (19.2) | 44.8 (19.5) | 46.4 (20.0) | 46.5 (19.5) | 47.4 (20.9) | 46.4 (19.8) | 48.2 (20.2) | 49.9 (21.1) | N/A |
 20 years and below (%) | 1312 (7.2) | 140 (8.1) | 206 (8.1) | 203 (7.8) | 164 (6.8) | 152 (6.6) | 144 (7.7) | 135 (7.7) | 92 (5.7) | 76 (6.0) | − 0.72 (0.01, − 26, 9.59) |
 21–30 years (%) | 3551 (19.6) | 357 (20.6) | 571 (22.3) | 548 (21.1) | 479 (19.8) | 440 (19.2) | 349 (18.7) | 323 (18.3) | 271 (16.8) | 213 (16.9) | − 0.83 (< 0.01, − 30, 9.59) |
 31–40 years (%) | 3898 (21.5) | 432 (24.9) | 584 (22.8) | 583 (22.4) | 524 (21.7) | 475 (20.7) | 368 (19.7) | 358 (20.3) | 345 (21.4) | 229 (18.2) | − 0.78 (< 0.01, − 28, 9.59) |
 41–50 years (%) | 2855 (15.8) | 251 (14.5) | 423 (16.5) | 407 (15.7) | 389 (16.1) | 365 (15.9) | 297 (15.9) | 283 (16.1) | 257 (16.0) | 183 (14.5) | − 0.06 (0.92, − 2, 9.59) |
 51–60 years (%) | 2070 (11.4) | 181 (10.4) | 257 (10.0) | 287 (11.1) | 264 (10.9) | 304 (13.3) | 194 (10.4) | 217 (12.3) | 203 (12.6) | 163 (12.9) | 0.50 (0.08, 18, 9.59) |
 61–70 years (%) | 1829 (10.1) | 178 (10.2) | 211 (8.2) | 243 (9.4) | 235 (9.7) | 244 (10.7) | 193 (10.3) | 202 (11.5) | 182 (11.3) | 141 (11.2) | 0.61 (0.03, 22, 9.59) |
 70 + years (%) | 2584 (14.3) | 198 (11.4) | 306 (12.0) | 326 (12.6) | 363 (15.0) | 310 (13.5) | 321 (17.2) | 245 (13.9) | 259 (16.1) | 256 (20.3) | 0.78 (< 0.01, 28, 9.59) |
HIV + (%) | 6444 (35.6) | 649 (37.4) | 1093 (42.7) | 1029 (39.6) | 878 (36.3) | 726 (31.7) | 623 (33.4) | 593 (33.6) | 495 (30.8) | 358 (28.4) | − 0.72 (< 0.01, − 26, 9.59) |
TB (%) | 2646 (14.6) | 317 (18.2) | 511 (20.0) | 483 (18.6) | 301 (12.4) | 261 (11.4) | 204 (10.9) | 208 (11.8) | 215 (13.4) | 146 (11.6) | − 0.44 (0.12, − 16, 9.59) |
DM (%) | 1648 (9.1) | 111 (6.4) | 160 (6.3) | 205 (7.9) | 244 (10.1) | 248 (10.8) | 211 (11.3) | 146 (8.3) | 178 (11.1) | 145 (11.5) | 0.72 (< 0.01, 26, 9.59) |
HTN (%) | 2142 (11.8) | 124 (7.1) | 207 (8.1) | 247 (9.5) | 306 (12.7) | 329 (14.4) | 260 (13.9) | 201 (11.4) | 210 (13.1) | 258 (20.5) | 0.67 (0.02, 24, 9.59) |